My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

234.00 +1.64 (+0.71%)

Official Closing Price Updated: 7:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

89 90 Next >

Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)

July 28, 2024

From Alector, Inc.

Via GlobeNewswire

AbbVie Wins Analyst Confidence with Q2 Beat, Diverse Portfolio Fuels Long-Term Growth Expectations ↗

July 26, 2024

AbbVie reports Q2 earnings with adjusted EPS of $2.65, surpassing expectations. Net revenues hit $14.46 billion, reflecting a 4.3% increase. Analysts maintain a positive outlook with increased price...

Via Benzinga

Lockheed Martin To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday ↗

July 26, 2024

Via Benzinga

Why AbbVie Stock Was Cruising Higher on Thursday ↗

July 25, 2024

The market was impressed with a notable increase in full-year guidance.

Via The Motley Fool

Peeling Back The Layers: Exploring AbbVie Through Analyst Insights ↗

July 19, 2024

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today ↗

July 18, 2024

Via Benzinga

AbbVie Unusual Options Activity ↗

July 17, 2024

Via Benzinga

AbbVie (ABBV) Q2 2024 Earnings Call Transcript ↗

July 25, 2024

ABBV earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday? ↗

July 25, 2024

Wall Street strongly rebounded Thursday after Wednesday’s slump, driven by stronger-than-expected economic growth in the last quarter, countering concerns of a slowdown.

Via Benzinga

Topics Economy

ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q2 2024 ↗

July 25, 2024

ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

AbbVie Stock News: Why ABBV Is the Top Trending Ticker Today ↗

July 25, 2024

AbbVie stock is the top trending ticker on Yahoo Finance Thursday earnings news has ABBV investors pumped up this morning.

Via InvestorPlace

AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs ↗

July 25, 2024

AbbVie Inc. reported Q2 adjusted EPS of $2.65, beating the $2.57 consensus, with net revenues at $14.46 billion. Immunology sales rose to $6.97 billion, while Humira declined 29.8%. Oncology and...

Via Benzinga

Topics Earnings

AbbVie Slides Despite Beating Second-Quarter Views, Raising Guidance ↗

July 25, 2024

The company's biggest drug, Humira, is about to give way to Skyrizi when it comes to sales power.

Via Investor's Business Daily

Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

July 25, 2024

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:AXSM) EQNX::TICKER_END

Via FinancialNewsMedia

Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

July 25, 2024

From FN Media Group LLC

Via GlobeNewswire

Is AbbVie the Best Dividend Stock for You? ↗

July 25, 2024

The drug company has a famously strong dividend record -- and that looks set to continue.

Via The Motley Fool

7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio ↗

July 24, 2024

With political rumblings poised to make things exciting, investors may turn to the stability of trustworthy dividend stocks.

Via InvestorPlace

Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House ↗

July 25, 2024

Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech...

Via Benzinga

Topics Government Stocks

AbbVie Earnings Preview: Will Humira's Expiry, New CEO Fuel A Bullish Surge? ↗

July 24, 2024

AbbVie will report Q2 earnings on Thursday. Investors watch for Humira impact and signs of recovery under new CEO.

Via Benzinga

AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? ↗

July 22, 2024

The big pharma company's top drug is losing ground, but its dividend keeps rising.

Via The Motley Fool

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗

July 21, 2024

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Via Benzinga

10 Best Dividend Growth Stocks to Buy and Hold Forever ↗

July 21, 2024

Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.

Via The Motley Fool

7 High-Yield Dividend Stocks to Help Pay Your Bills ↗

July 17, 2024

It’s time to stop actively generating wealth and let your money work for you with high-yield dividend stocks to buy.

Via InvestorPlace

3 Absurdly Cheap Stocks to Buy and Hold for Years ↗

July 17, 2024

You can buy these solid stocks at some attractive discounts right now.

Via The Motley Fool

7 High-Yield Dividend Stocks Beating Inflation ↗

July 16, 2024

High-yield dividend stocks are one of the surest paths to beating inflation as the cost of everything remains high in mid-2024.

Via InvestorPlace

Topics Economy

3 Quantum AI Stocks That Could Redefine Computing ↗

July 16, 2024

Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap.

Via InvestorPlace

Topics Artificial Intelligence

7 Recession-Proof Stocks to Shield Your Portfolio in 2024 ↗

July 16, 2024

Recession-proof stocks gain momentum as concerns about AI bubble grow and other factors contribute to needing to safeguard portfolios.

Via InvestorPlace

Topics Artificial Intelligence

3 Spinoff Stocks You Should Buy Now: July 2024 ↗

July 15, 2024

Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early.

Via InvestorPlace

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

July 15, 2024

These companies stand out for their pedigrees, robust financials, and future growth prospects.

Via The Motley Fool

3 Dividend Growth Stocks to Buy and Hold ↗

July 14, 2024

What's better than a dividend? A dividend that's growing.

Via The Motley Fool

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

89 90 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.